Table 1. Clinical characteristics of patients.
| pre-CR | post-CR | |
|---|---|---|
| BW (kg) | 59.1 ± 15.0 | 62.0 ± 16.3* |
| BMI (kg/m2) | 22.4 ± 4.7 | 23.4 ± 5.1* |
| LVEF (%) | 30.0 ± 12.3 | 31.0 ± 11.6 |
| E/E’ | 20.0 ± 18.0 | 20.0 ± 14.1 |
| TRPG (mmHg) | 23.0 ± 8.1 | 25.0 ± 18.5 |
| Hb (g/dl) | 13.0 ± 2.9 | 12.9 ± 1.8 |
| TP (g/dl) | 7.1 ± 0.5 | 7.1 ± 0.5 |
| Alb (g/dl) | 4.5 ± 0.6 | 4.4 ± 0.6 |
| AST (U/l) | 24.4 ± 5.5 | 24.1 ± 5.3 |
| ALT (U/l) | 18.4 ± 8.7 | 17.2 ± 5.0 |
| CK (U/l) | 108.3 ± 107.5 | 114.7 ± 68.7 |
| BUN (mg/dl) | 19.3 ± 9.2 | 19.2 ± 10.1 |
| Cre (mg/dl) | 1.0 ± 0.4 | 1.0 ± 0.4 |
| UA (mg/dl) | 7.2 ± 1.5 | 7.0 ± 1.0 |
| BS (mg/dl) | 109.2 ± 26.4 | 104.0 ± 24.9 |
| TG (mg/dl) | 123.0 ± 79.9 | 158.0 ± 130.5 |
| T-cho (mg/dl) | 180.2 ± 46.9 | 177.9 ± 41.4 |
| HDL-cho (mg/dl) | 50.0 ± 12.5 | 53.7 ± 17.3 |
| NT-pro BNP (pg/ml) | 2,294.7 ± 2,310.7 | 2,553.2 ± 3,428.2 |
| SPPB (points) | 11.2 ± 1.4 | 11.2 ± 1.3 |
| Leg strength (%BW/kg) | 29.8 ± 11.6 | 28.5 ± 12.1 |
| Hand grip (kg) | 23.9 ± 7.1 | 24.3 ± 7.3 |
pre-CR: before phase II cardiac rehabilitation program; post-CR: after phase II cardiac rehabilitation program; BW: body weight; BMI: body mass index; LVEF: left ventricular ejection fraction; E/E’: early diastolic mitral valve flow to tissue annular velocity ratio; TRPG: tricuspid regurgitation pressure gradient; Hb: hemoglobin; TP: total protein; Alb: albumin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; CK: creatinine kinase; BUN: blood urea nitrogen; CK: creatinine; BUN: blood urea nitrogen; BS: blood sugar; TG: triglyceride; T-cho: total cholesterol; HDL-cho: high density lipoprotein cholesterol; NT-pro BNP: N terminal pro-brain natriuretic peptide; SPPB: short physical performance battery. Pre-CR and post-CR data were compared using Wilcoxon signed-rank test. *p<0.05. Values are means ± SD, n=12